Das · The Cochrane database of systematic reviews 2018 · systematic review and meta-analysis · n=7 studies (1529 participants)

Vitamin D as an adjunct to antibiotics for the treatment of acute childhood pneumonia.

Cited 62 times in the scientific literature.

Level 1 - systematic review of randomized trials

Systematic review and meta-analysis of randomized controlled trials

PubMed 30024634 · doi:10.1002/14651858.CD011597.pub2 · record verified 2026-08-29

What was done

This Cochrane systematic review searched CENTRAL, MEDLINE, Embase, ClinicalTrials.gov, and WHO ICTRP through July 2017 for randomized controlled trials evaluating vitamin D supplementation as an adjunct to antibiotics in children aged 1 month to 5 years hospitalized with acute community-acquired pneumonia. Reviewers independently extracted data and assessed certainty using GRADE.

What was found

Seven RCTs with 1,529 children from low-income countries were included. Vitamin D regimens varied (single 100,000 IU dose in 4 trials; 1,000–2,000 IU/day for 5 days in 2 trials; 50,000 IU/day for 2 days in 1 trial). Adjunctive vitamin D showed inconclusive effects across all reported outcomes: - Time to resolution of acute illness: MD -0.95 hours (95% CI -6.14 to 4.24; 3 studies, 935 children; low-quality evidence) - Duration of hospitalization: MD 0.49 hours (95% CI -8.41 to 9.40; 4 studies, 835 children; very low-quality evidence) - Time to resolution of fever: MD 1.66 hours (95% CI -2.44 to 5.76; 4 studies, 584 children; very low-quality evidence) - Mortality: RR 0.97 (95% CI 0.06 to 15.28; 1 study, 193 children; very low-quality evidence) No major adverse events were reported.

Why it matters

Adjunctive vitamin D does not show clear clinical benefit for reducing illness duration, hospital stays, or mortality in young children hospitalized with acute pneumonia.

Limits

Certainty of evidence was rated low to very low across all outcomes due to serious study limitations, imprecision from small numbers of events/wide confidence intervals, indirectness, and inconsistency. Only one trial confirmed diagnosis using microbiological and radiological criteria. Dosing regimens varied substantially, and all studies were conducted in low-income countries.

Cited by